ChiCTR2400091486 版本V1.0 版本创建时间2024/10/29 15:15:05 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400091486 

最近更新日期:

Date of Last Refreshed on:

2024-10-29 15:14:51 

注册时间:

Date of Registration:

2024-10-29 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

急性呼吸窘迫综合征专病队列数据库建设及应用

Public title:

Construction and application of a specialized cohort database for acute respiratory distress syndrome

注册题目简写:

English Acronym:

研究课题的正式科学名称:

急性呼吸窘迫综合征专病队列数据库建设及应用

Scientific title:

Construction and application of a specialized cohort database for acute respiratory distress syndrome

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王岗 

研究负责人:

王岗 

Applicant:

Gang Wang 

Study leader:

Gang Wang 

申请注册联系人电话:

Applicant telephone:

+86 18092848496

研究负责人电话:

Study leader's
telephone:

+86 29 87679633

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

gang_wang@xjtu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

gang_wang@xjtu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

陕西省西安市新城区西五路157号西安交通大学第二附属医院

研究负责人通讯地址:

皇城西路30号交大二院南院

Applicant address:

The Second Affiliated Hospital of Xi’an Jiaotong University 157 Xi 5 Lu, Xi’an, Shaanxi, PR China

Study leader's address:

Second Affiliated Hospital of Xian Jiaotong University Xian 710004 Shaanxi Province China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

西安交通大学第二附属医院

Applicant's institution:

The Second Affiliated Hospital of Xi’an Jiaotong University

研究负责人所在单位:

西安交通大学第二附属医院

Affiliation of the Leader:

Xi'an Jiaotong University Second Affiliated Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2024伦审144

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

西安交通大学第二附属医院 医学伦理委员会

Name of the ethic committee:

The medical ethics committee of the Second Affiliated Hospital of Xi'an Jiaotong University

伦理委员会批准日期:

Date of approved by ethic committee:

2024-08-27 00:00:00

伦理委员会联系人:

李涵

Contact Name of the ethic committee:

Li Han

伦理委员会联系地址:

皇城西路30号交大二院南院

Contact Address of the ethic committee:

Second Affiliated Hospital of Xian Jiaotong University Xian 710004 Shaanxi Province China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 29 87678326

伦理委员会联系人邮箱:

Contact email of the ethic committee:

lunli326@163.com

研究实施负责(组长)单位:

西安交通大学第二附属医院

Primary sponsor:

Xi'an Jiaotong University Second Affiliated Hospital

研究实施负责(组长)单位地址:

皇城西路30号交大二院南院

Primary sponsor's address:

Second Affiliated Hospital of Xian Jiaotong University Xian 710004 Shaanxi Province China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

陕西

市(区县):

Country:

China

Province:

Shaanxi

City:

单位(医院):

西安交通大学第二附属医院

具体地址:

皇城西路30号交大二院南院

Institution
hospital:

Xi'an Jiaotong University Second Affiliated Hospital

Address:

Second Affiliated Hospital of Xian Jiaotong University Xian 710004 Shaanxi Province China

经费或物资来源:

2023年国家区域医疗中心项目

Source(s) of funding:

2023 National Regional Medical Center project

研究疾病:

急性呼吸窘迫综合征  

Target disease:

Acute respiratory distress syndrome

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

建立一个基于规范化治疗的ARDS专病队列数据库,采集ARDS诊断、治疗及预后的全程数据,同时建立ARDS生物样本库,开展ARDS真实世界研究,探究影响ARDS患者预后的高危因素及个体化诊疗策略,为后续高质量的临床研究提供证据,并进一步提升ARDS患者诊疗和临床路径规范化。  

Objectives of Study:

Establish an ARDS specialized team database based on standardized treatment, collect comprehensive data on ARDS diagnosis, treatment, and prognosis, concurrently establish an ARDS biospecimen bank, conduct real-world research on ARDS, explore high-risk factors influencing the prognosis of ARDS patients and individualized diagnostic and therapeutic strategies, provide evidence for subsequent high-quality clinical research, and further enhance the standardization of ARDS patient diagnosis, treatment, and clinical pathways

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.年龄≥18岁;
2.符合ARDS 2023年全球新定义诊断标准;
3.患者或家属签署知情同意书;

Inclusion criteria

1.Aged 18 years and above;
2.With diagnostic criteria of the new global definition of ARDS in 2023;
3.Patients or their family members sign the informed consent form;

排除标准:

1.同时参与其他探索性临床研究的患者; 2.妊娠期、哺乳期女性或可能处于妊娠中的女性; 3.肿瘤晚期或恶病质的患者(预期生存期不超过3月); 4.患者或家属拒绝签署知情同意书

Exclusion criteria:

1.Patients concurrently participating in other exploratory clinical studies; 2.Pregnant, lactating women, or women who may be pregnant; 3.Patients with advanced cancer or cachexia (expected survival of less than 3 months; 4. The patient or family member refuses to sign the informed consent form

研究实施时间:

Study execute time:

From 2024-10-29 00:00:00 To 2044-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-10-29 00:00:00 To 2044-12-31 00:00:00

干预措施:

Interventions:

组别:

专病队列建设不进行具体分组

样本量:

5000

Group:

Specific groups are not used in the construction of special disease cohort

Sample size:

干预措施:

专病队列建设不具体设置暴露因素

干预措施代码:

Intervention:

Specific exposure factors are not specified in the construction of specific disease cohort

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

陕西 

市(区县):

 

Country:

China

Province:

Shaanxi

City:

单位(医院):

西安交通大学第二附属医院 

单位级别:

三级甲等 

Institution
hospital:

Xi'an Jiaotong University Second Affiliated Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

陕西 

市(区县):

 

Country:

China

Province:

Shaanxi

City:

单位(医院):

西安医学院第一附属医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital of Xi'an Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

陕西 

市(区县):

 

Country:

China

Province:

Shaanxi

City:

单位(医院):

西安医学院第二附属医院 

单位级别:

三级甲等 

Institution
hospital:

Second Affiliated Hospital of Xi'an Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

陕西 

市(区县):

 

Country:

China

Province:

Shaanxi

City:

单位(医院):

西安交通大学第一附属医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital of Xi'an Jiaotong University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

社会人口学信息

指标类型:

主要指标

Outcome:

Sociodemographic information

Type:

Primary indicator

测量时间点:

D1

测量方法:

从临床病案系统录入

Measure time point of outcome:

D1

Measure method:

Input from clinical records system

指标中文名:

诊疗过程

指标类型:

主要指标

Outcome:

Diagnosis and treatment process

Type:

Primary indicator

测量时间点:

ICU入院期间

测量方法:

从临床病案系统录入

Measure time point of outcome:

During ICU admission

Measure method:

Input from clinical records system

指标中文名:

ICU死亡、出院死亡、28天死亡

指标类型:

主要指标

Outcome:

ICU, hospital, and 28-day mortality

Type:

Primary indicator

测量时间点:

出ICU时、出院时、距离入ICU28天

测量方法:

从临床病案系统录入

Measure time point of outcome:

At the time of leaving the ICU, at the time of discharge, 28 days from admission to the ICU

Measure method:

Input from clinical records system

指标中文名:

住院期间各项医疗花费及非医疗成本

指标类型:

主要指标

Outcome:

Hospitalization expenses

Type:

Primary indicator

测量时间点:

出ICU时

测量方法:

从临床病案系统录入,填写调查问卷

Measure time point of outcome:

At the time of leaving the ICU

Measure method:

Input from the clinical records system, fill in the questionnaire

指标中文名:

CRRT设置

指标类型:

主要指标

Outcome:

CRRT setting

Type:

Primary indicator

测量时间点:

ICU入院期间

测量方法:

从临床病案系统录入

Measure time point of outcome:

During ICU admission

Measure method:

Input from clinical records system

指标中文名:

呼吸机参数设置

指标类型:

主要指标

Outcome:

ventilator parameter setting

Type:

Primary indicator

测量时间点:

ICU入院期间

测量方法:

从临床病案系统录入

Measure time point of outcome:

During ICU admission

Measure method:

Input from clinical records system

指标中文名:

出入量

指标类型:

主要指标

Outcome:

intake and exit volume

Type:

Primary indicator

测量时间点:

ICU入院期间

测量方法:

从临床病案系统录入

Measure time point of outcome:

During ICU admission

Measure method:

Input from clinical records system

指标中文名:

血气分析

指标类型:

主要指标

Outcome:

blood gas analysis

Type:

Primary indicator

测量时间点:

ICU入院期间

测量方法:

从临床病案系统录入

Measure time point of outcome:

During ICU admission

Measure method:

Input from clinical records system

指标中文名:

POCT指标

指标类型:

主要指标

Outcome:

POCT index

Type:

Primary indicator

测量时间点:

ICU入院期间

测量方法:

从临床病案系统录入

Measure time point of outcome:

During ICU admission

Measure method:

Input from clinical records system

指标中文名:

生命体征

指标类型:

主要指标

Outcome:

vital signs

Type:

Primary indicator

测量时间点:

ICU入院期间

测量方法:

从临床病案系统录入

Measure time point of outcome:

During ICU admission

Measure method:

Input from clinical records system

指标中文名:

病原学

指标类型:

主要指标

Outcome:

etiology

Type:

Primary indicator

测量时间点:

ICU入院期间

测量方法:

从临床病案系统录入

Measure time point of outcome:

During ICU admission

Measure method:

Input from clinical records system

指标中文名:

入ICU诊断

指标类型:

主要指标

Outcome:

ICU admission diagnosis

Type:

Primary indicator

测量时间点:

D1

测量方法:

从临床病案系统录入

Measure time point of outcome:

D1

Measure method:

Input from clinical records system

指标中文名:

入科情况

指标类型:

主要指标

Outcome:

admission status

Type:

Primary indicator

测量时间点:

D1

测量方法:

从临床病案系统录入

Measure time point of outcome:

D1

Measure method:

Input from clinical records system

指标中文名:

血常规

指标类型:

主要指标

Outcome:

blood routine examination

Type:

Primary indicator

测量时间点:

D1、D2、D3、D5、D7

测量方法:

从临床病案系统录入

Measure time point of outcome:

D1、D2、D3、D5、D7

Measure method:

Input from clinical records system

指标中文名:

肝功能

指标类型:

主要指标

Outcome:

liver function

Type:

Primary indicator

测量时间点:

D1、D2、D3、D5、D7

测量方法:

从临床病案系统录入

Measure time point of outcome:

D1、D2、D3、D5、D7

Measure method:

Input from clinical records system

指标中文名:

肾功能

指标类型:

主要指标

Outcome:

renal function

Type:

Primary indicator

测量时间点:

D1、D2、D3、D5、D7

测量方法:

从临床病案系统录入

Measure time point of outcome:

D1、D2、D3、D5、D7

Measure method:

Input from clinical records system

指标中文名:

电解质

指标类型:

主要指标

Outcome:

electrolyte

Type:

Primary indicator

测量时间点:

D1、D2、D3、D5、D7

测量方法:

从临床病案系统录入

Measure time point of outcome:

D1、D2、D3、D5、D7

Measure method:

Input from clinical records system

指标中文名:

心肌酶

指标类型:

主要指标

Outcome:

myocardial enzyme

Type:

Primary indicator

测量时间点:

D1、D2、D3、D5、D7

测量方法:

从临床病案系统录入

Measure time point of outcome:

D1、D2、D3、D5、D7

Measure method:

Input from clinical records system

指标中文名:

凝血相关指标

指标类型:

主要指标

Outcome:

Clotting related indicators

Type:

Primary indicator

测量时间点:

D1、D2、D3、D5、D7

测量方法:

从临床病案系统录入

Measure time point of outcome:

D1、D2、D3、D5、D7

Measure method:

Input from clinical records system

指标中文名:

微生物三项

指标类型:

主要指标

Outcome:

Microbial triad

Type:

Primary indicator

测量时间点:

D1、D2、D3、D5、D7

测量方法:

从临床病案系统录入

Measure time point of outcome:

D1、D2、D3、D5、D7

Measure method:

Input from clinical records system

指标中文名:

细胞因子

指标类型:

主要指标

Outcome:

cytokines

Type:

Primary indicator

测量时间点:

D1、D2、D3、D5、D7

测量方法:

从临床病案系统录入

Measure time point of outcome:

D1、D2、D3、D5、D7

Measure method:

Input from clinical records system

指标中文名:

抗Xa因子

指标类型:

主要指标

Outcome:

Anti-xa factor

Type:

Primary indicator

测量时间点:

D1、D2、D3、D5、D7

测量方法:

从临床病案系统录入

Measure time point of outcome:

D1、D2、D3、D5、D7

Measure method:

Input from clinical records system

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

外周静脉血

组织:

Sample Name:

Peripheral venous blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

支气管肺泡灌洗液

组织:

Sample Name:

Bronchoalveolar lavage fluid

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not shared

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用Redcap数据管理系统采集数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Collecting data using the Redcap data management system

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2024-10-29 15:14:51